Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Preprint
MSA-2 formulation for in vivo dosing
Last updated date: Jan 11, 2021 Views: 918 Forks: 0
Download PDF
Ask a
question
How to
cite
Favorite
MSA-2 was solubilized in PBS with mild pH adjustment to dose mice at 5 ml/kg for all routes of administration
Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
- Perera, S(2021). MSA-2 formulation for in vivo dosing. Bio-protocol Preprint. bio-protocol.org/prep740.
- Pan, B., Perera, S. A., Piesvaux, J. A., Presland, J. P., Schroeder, G. K., Cumming, J. N., Trotter, B. W., Altman, M. D., Buevich, A. V., Cash, B., Cemerski, S., Chang, W., Chen, Y., Dandliker, P. J., Feng, G., Haidle, A., Henderson, T., Jewell, J., Kariv, I., Knemeyer, I., Kopinja, J., Lacey, B. M., Laskey, J., Lesburg, C. A., Liang, R., Long, B. J., Lu, M., Ma, Y., Minnihan, E. C., O’Donnell, G., Otte, R., Price, L., Rakhilina, L., Sauvagnat, B., Sharma, S., Tyagarajan, S., Woo, H., Wyss, D. F., Xu, S., Bennett, D. J. and Addona, G. H.(2020). An orally available non-nucleotide STING agonist with antitumor activity . Science 369(6506). DOI: 10.1126/science.aba6098
Category
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Post a Question1 Q&A
This protocol preprint was submitted via the "Request
a Protocol" track.
